Tempest Therapeutics, Inc. Adjustments to Additional Paid in Capital, Other
Tempest Therapeutics, Inc. (TPST) reported Adjustments to Additional Paid in Capital, Other of -$6.42 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2022-03-29
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-12-31 was $0.00.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-09-30 was -$346.00K.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-06-30 was -$6.07M.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-03-31 was $0.00.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, other for fiscal 2021 was -$6.42M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$346.00K derived: sum of 2 quarters · filed 2022-03-29 | -$6.42M derived: sum of 3 quarters · filed 2022-03-29 | -$6.42M 10-K · filed 2022-03-29 |
| 2021-09-30 | -$346.00K 10-Q · filed 2021-11-10 | -$6.42M derived: sum of 2 quarters · filed 2021-11-10 | -$6.42M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$6.07M 10-Q · filed 2021-08-12 | -$6.07M 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |